Waldencast plc (Nasdaq: WALD) is a special purpose acquisition company sponsored by Waldencast Partners LP, targeting the beauty and wellness sector. The vehicle completed its initial public offering in 2021 and, as of its 10-Q filing dated May 16, 2022, remained in the pre-combination phase while pursuing its announced transactions with Obagi Medical and Milk Makeup. The filing, bearing accession number 0001213900-22-027228, reflects the company's financial position during the period ending March 31, 2022, ahead of the consummation of its business combination later that year. Investors and analysts tracking beauty-sector SPACs can sign up at SpacDesk for full filing history, status timelines, and institutional-grade data on WALD and the broader SPAC universe.